A detailed history of Relyea Zuckerberg Hanson LLC transactions in Pfizer Inc stock. As of the latest transaction made, Relyea Zuckerberg Hanson LLC holds 15,250 shares of PFE stock, worth $407,480. This represents 0.07% of its overall portfolio holdings.

Number of Shares
15,250
Previous 13,346 14.27%
Holding current value
$407,480
Previous $373,000 18.23%
% of portfolio
0.07%
Previous 0.06%

Shares

25 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 17, 2024

BUY
$27.7 - $31.39 $52,740 - $59,766
1,904 Added 14.27%
15,250 $441,000
Q2 2024

Oct 31, 2024

BUY
$25.26 - $29.6 $55,673 - $65,238
2,204 Added 19.78%
13,346 $373,000
Q2 2024

Jul 17, 2024

BUY
$25.26 - $29.6 $55,673 - $65,238
2,204 Added 19.78%
13,346 $373,000
Q1 2024

Oct 31, 2024

BUY
$25.89 - $29.73 $14,161 - $16,262
547 Added 5.16%
11,142 $309,000
Q1 2024

Apr 22, 2024

BUY
$25.89 - $29.73 $14,161 - $16,262
547 Added 5.16%
11,142 $309,000
Q4 2023

Oct 31, 2024

SELL
$26.13 - $33.94 $86,751 - $112,680
-3,320 Reduced 23.86%
10,595 $305,000
Q4 2023

Jan 18, 2024

SELL
$26.13 - $33.94 $86,751 - $112,680
-3,320 Reduced 23.86%
10,595 $305,000
Q3 2023

Oct 31, 2024

SELL
$32.09 - $37.51 $42,840 - $50,075
-1,335 Reduced 8.75%
13,915 $461,000
Q3 2023

Oct 16, 2023

SELL
$32.09 - $37.51 $81,283 - $95,012
-2,533 Reduced 15.4%
13,915 $461,000
Q2 2023

Jul 17, 2023

BUY
$36.12 - $41.79 $169,041 - $195,577
4,680 Added 39.77%
16,448 $603,000
Q1 2023

Apr 18, 2023

SELL
$39.39 - $51.28 $22,058 - $28,716
-560 Reduced 4.54%
11,768 $480,000
Q4 2022

Jan 18, 2023

BUY
$41.75 - $54.5 $140,948 - $183,992
3,376 Added 37.71%
12,328 $0
Q3 2022

Nov 02, 2022

SELL
$43.76 - $53.42 $72,816 - $88,890
-1,664 Reduced 15.67%
8,952 $392,000
Q2 2022

Jul 18, 2022

BUY
$46.53 - $55.17 $24,428 - $28,964
525 Added 5.2%
10,616 $557,000
Q1 2022

Apr 19, 2022

BUY
$45.75 - $56.69 $2,241 - $2,777
49 Added 0.49%
10,091 $536,000
Q4 2021

Jan 27, 2022

BUY
$41.32 - $61.25 $132,926 - $197,041
3,217 Added 47.14%
10,042 $530,000
Q4 2021

Jan 14, 2022

SELL
$41.32 - $61.25 $83,507 - $123,786
-2,021 Reduced 22.85%
6,825 $251,000
Q3 2021

Oct 22, 2021

BUY
$39.25 - $50.42 $56,049 - $71,999
1,428 Added 19.25%
8,846 $380,000
Q2 2021

Jul 23, 2021

BUY
$35.91 - $40.68 $16,805 - $19,038
468 Added 6.73%
7,418 $290,000
Q1 2021

Apr 29, 2021

BUY
$33.49 - $37.77 $4,186 - $4,721
125 Added 1.83%
6,950 $267,000
Q4 2020

Jan 28, 2021

SELL
$33.47 - $42.56 $2,510 - $3,192
-75 Reduced 1.09%
6,825 $251,000
Q3 2020

Oct 16, 2020

BUY
$31.75 - $37.25 $9,683 - $11,361
305 Added 4.62%
6,900 $240,000
Q2 2020

Jul 13, 2020

SELL
$30.12 - $36.54 $14,246 - $17,283
-473 Reduced 6.69%
6,595 $216,000
Q1 2020

May 05, 2020

BUY
$27.03 - $38.62 $837 - $1,197
31 Added 0.44%
7,068 $231,000
Q4 2019

Jan 15, 2020

BUY
$32.92 - $37.36 $231,658 - $262,902
7,037 New
7,037 $276,000

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $150B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track Relyea Zuckerberg Hanson LLC Portfolio

Follow Relyea Zuckerberg Hanson LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Relyea Zuckerberg Hanson LLC, based on Form 13F filings with the SEC.

News

Stay updated on Relyea Zuckerberg Hanson LLC with notifications on news.